Q4 2020

Filed Mar 8, 2021 · 10-K · 67 days after period end · 0001731122-21-000336

Q4 2020 · 10-K

derived · Computed from the longer spans the company filed.

Revenue

$1.24M

derivedno prior Q4 2019 on file

Net Income

-$22.77M

derivedN/M vs Q4 2019

EPS, diluted—

Same quarter

Metric	Q4 2020derived from reported figures	Q4 2019derived from reported figures	Q4 2018derived from reported figures	Q4 2017derived from reported figures
Revenue	$1.24M	—	$296.80K	$155.70K
Net Income	-$22.77M	-$4.16M	-$14.52K	-$101.89K

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Endovia Health Sciences, Inc. · CIK 1553788 · Engraved from SEC EDGAR